Endotoxin contamination of reagents used during isolation and purification of human pancreatic islets

Transplantation Proceedings

Volumn 30, Issue 2, 1998, Pages 345-346

  Linetsky, E ^a   Inverardi, L ^a   Kenyon, N S ^a   Alejandro, R ^a   Ricordi, C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; COLLAGENASE; EURO COLLINS SOLUTION; FICOLL; HUMAN SERUM ALBUMIN; LIBERASE; REAGENT; UNCLASSIFIED DRUG; WATER;

AUTOIMMUNITY; CONFERENCE PAPER; FETAL CALF SERUM; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT REJECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE ACTIVATION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY;

CELL SEPARATION; DRUG CONTAMINATION; ENDOTOXINS; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGE ACTIVATION; MACROPHAGES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031968550     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)01297-9     Document Type: Conference Paper

References (5)

1. Kaufman DB, Platt JL, Rabe FL, et al: J Exp Med 172:201, 1990
2. Nussler AK, Ricordi C, Carroll PB, et al: Transplant Proc 24:2997, 1992
3. Rilo HLR, Fontes PA, Nussler AK, et al: Transplant Proc 25:988, 1993
4. Ricordi C: New Dev Transpl Med 2:7, 1995
5. Center for Drug Evaluation and Research. US Department of Health and Human Services Public Health Service. FDA. Guide-lines on validation of the LAL test. December 1987